The role of 123 I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131 I-scanning: avoidance of negative therapeutic uptake due to stunning-Reference-Cited by-同舟云学术

The role of 123 I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131 I-scanning: avoidance of negative therapeutic uptake due to stunning

Published:2001-10 Issue:4 Volume:55 Page:515-521
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Siddiqi A.,Foley R. R.,Britton K. E.,Sibtain A.,Plowman P. N.,Grossman A. B.,Monson J. P.,Besser G. M.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2001.01376.x/fullpdf

Reference24 articles.

1. Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan;Baudin;Journal of Clinical Endocrinology and Metabolism,1996

2. Serum thyroglobulin measurements in thyroid cancer: evaluation of false positive results;Black;Clinical Endocrinology (Oxford),1991

3. Radioimmunoscintigraphy in tumour identification;Britton;Cancer Surveys,1987

4. Where next and how? Highlights lecture;Britton;European Journal of Nuclear Medicine,1998

5. Thyroid stunning;Coakley;European Journal of Nuclear Medicine,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Dual and Triple Energy Window Scatter Correction on I-123 Postsurgical Thyroid SPECT/CT Imaging Using a Phantom with Small Sizes of Thyroid Remnants;Life;2024-01-11

2. Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients;Cancers;2023-04-11

3. Thyroid and Parathyroid Cancer;Multimodality Imaging and Intervention in Oncology;2023

4. Usefulness of 123I-spect/ct to assess the response to initial therapy in differentiated thyroid cancer patients;Endocrine;2021-05-04

5. Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases;Endocrine;2020-03-16